Introduction
The biotechnology industry has uncharacteristically high development costs, and therefore greater investment needs. This situation is complicated by the fact that the unpredictable nature of biotechnology research and discovery makes investment riskier than in other industries. Due to the high cost of research, substantial funding is required to support a new biotechnology startup and sustain it from the initial innovation all the way through the approval process to a marketable product; product regulation, biological reagents and machinery needed for research can make the process extremely costly. Such large financial needs combined with the high level of prerequisite knowledge necessary to predict likelihood of success from a given line of research create a very high risk environment for investors.
Techneome aims to ease this risk by helping investors decide whether companies have, at the very least, feasible, high-impact research targets. This service is beneficial to both investors and companies; independent analysis ensures that poorly-considered startups will not exhaust available investment funds, and instead encourages dollars to go towards quality organizations. On the whole, this makes biotechnology a much more reliable investment.
Published scientific research undergoes a process of peer review prior to being published - Techneome seeks to make sure that private sector biotechnology ventures undergo similarly rigorous scrutiny prior to investment.
Why Techneome?
Techneome leverages brainpower from the California Institute of Technology, a world-renowned university which attracts top biology minds as undergraduates, staff, graduate students, postdoctoral scholars, and faculty. We have expertise, a strong reputation for scientific ethics, and freedom from conflicts of interest, allowing us to provide candid evaluations of prospective products from a scientific standpoint. We provide evaluated companies with our strong commitment to nondisclosure and protection of their trade secrets, while offering investors the opportunity to test the waters before jumping in.
For more information, continue to the about page describing Techneome, or contact us directly.